Pharmacy

PGY 2 Infectious Diseases Residency

PROGRAM DESCRIPTION

Our two PGY 2 ID Pharmacy residents will progress through a series of customized rotations and longitudinal learning experiences during the 12-month period. Our rotations are completed as a mix of 5-week focused blocks and longitudinal experiences. These blocks include an orientation block, seven required rotation blocks, and two elective blocks. Residents will have an antimicrobial stweardship service commitment of every 3rd weekend.

Required Experiences:

  • Orientation/Training
  • ID Consult Service x 3 (with progressive responsibilities)
  • Antimicrobial Stewardship (focused)
  • System Antimicrobial Stewardship (focused)
  • Microbiology/Infection Control
  • ID Administration

Elective Experiences (subject to change):

  • MICU or SICU
  • Information Technology
  • Emergency Medicine
  • Pediatrics
  • ID Ambulatory Clinic (focused)
  • Information Technology
  • Special populations (oncology or offsite transplant when available

Longitudinal Experiences:

  • Shared Chief Resident Experience
  • Medication Use (Drug Information)
  • Research Project
  • Restricted Antimicrobial Approval
  • ID Ambulatory Clinic (HIV/Hepatitis C)
  • Antimicrobial Stewardship
  • Presentations/Teaching

PHARMACY RESIDENT BENEFITS

  • Yearly stipend of $49,500
  • Insurance (Health, Dental, Life, Disability)
  • Paid leave
  • Travel allowance
  • Opportunity to participate in 403B retirement plan
  • Relocation assistance (as available)
  • Resident office, laptop computer, and iPhone

APPLICATION REQUIREMENTS

We participate in the PhORCAS residency application process. (PhORCAS: Pharmacy Online Residency Centralized Application Service). PhORCAS is the result of a partnership between the American Society of Health-System Pharmacists (ASHP) and Liaison International. It also incorporates registration with the National Matching Service (NMS).

Our application for the PGY-2 Infectious Disease Pharmacy Residency program requires submission of the following information through PhORCAS:

  1. Letter of Intent
    • This letter must be personalized to Carilion and include answers to the following two questions.
  2. Curriculum vitae
  3. A minimum of three (3) references submitted through PhORCAS
  4. Academic transcripts

Completed applications are due by December 30, 2016. Residency applicants will be notified by January 25, 2017, regarding an offer for an on-site interview.

Contact Information


Please feel free to contact us with any questions related to our program and/or the application process.

Nathan A. Everson, PharmD, AAHIVP
PGY-2 Infectious Diseases Residency Program Director
naeverson@carilionclinic.org
540-206-6815
P.O. Box 13367
Department of Pharmacy
Roanoke, VA 24033-3367

Carilion is an Equal Opportunity/Affirmative Action Employer